The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs

DOI: 10.1186/s13063-018-2877-z

Keywords: US Food and Drug Administration (FDA), Drug regulation, Marketing authorization, Approval package, Drugs and biologics, Clinical trials, Cancer, Evidence synthesis, Systematic review

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text